The Federal Reserve held interest rates steady but indicated that there would be at least one rate increase by the end of the year. The markets closed mixed with the Dow gaining 41 points to 22,412 while Nasdaq slipped 5 points to 6,456.
On the upside
Shares of Argentinian online travel company Despegar (NYSE: DESP) surged in its market debut.
The stock price of biopharmaceutical Zai Lab (Nasdaq: ZLAB) leaped on its first trading day.
Arbutus Biopharma's (Nasdaq: ABUS) licensee Alnylam Pharmaceuticals (Nasdaq: ALNY) reported upbeat APOLLO Phase 3 study results of patisiran, which is enabled by Arbutus's lipid nanoparticle technology.
On the downside
Maxwell Technologies (Nasdaq: MXWL) will offer $50 million in convertible senior notes.
Iovance Biotherapeutics (Nasdaq: IOVA) will offer $50 million of its common stock through a public offering.
Nabriva Therapeutics (Nasdaq: NBRV) priced its public offering of more than 9.4 million common shares at the discounted price of $8.50 per share.
In the broad market, advancing issues outpaced decliners by a margin of 5 to 4 on the NYSE and by nearly 4 to 3 on Nasdaq. The broader S&P 500 added a point to 2,508. Bitcoin climbed $65 to $3,961.
